which glp 1 makes you lose the most weight Unlocking Power of GLP-1 For Loss The GLP-1 Access Gap: Mapping

Robust clinical evidence supports significant weight loss and cardiometabolic benefits for eligible patients

Acta (BBA)-Proteins Proteomics

In the head-to-head SURMOUNT-5 trial (NEJM, 2025), Mounjaro produced 20.2% average weight loss vs 13.7% for Wegovy over 72 weeks

Most information comes from patient forums and social media, where reports are mixed: some describe renewed appetite suppression on re-start, while others report weight gain during breaks and significant nausea on resuming previous doses, often requiring a full re-titration

Sthr M, Hansen PB, Madsen K, Vanhoutte PM, Nsing RM, Jensen BL

A new concept in the treatment of Peyronies disease